Oncology Regional Marketing Director (West Coast)

San Francisco, CA (Remote)

$181K/yr – $233K/yrDirector/Executive3+ years expFull time

Posted 2 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own regional oncology market execution by translating scientific insights into commercial programs, leading cross-functional initiatives, and shaping speaker and advisory activities to drive regional impact.

  • Regional Engagement: Develop and execute the regional engagement plan for Stemline’s oncology/hematology products.
  • Cross-functional Leadership: Lead or serve as a key commercial member on high-visibility, company-wide initiatives.
  • Market Translation: Turn scientific, clinical, and market research into actionable commercial activities.
  • Advisory Boards & Medical Affairs: Develop and implement advisory boards across academic and community HCPs, partnering with medical affairs.
  • Stakeholder Interaction: Engage opinion leaders and oncology medical associations.
  • Regional Conference Planning: Develop and execute the Regional Conference plan for oncology meetings.
  • Speakers’ Bureaus: Build strategic and operational readiness plans for speakers’ bureaus (nomination, training, content).
  • Educational Content: Aid in Peer to Peer and Speaker Program content creation, such as slide decks and patient cases.
  • Regional Tactics & Compliance: Coordinate regional unbranded/branded tactics within strategy and budgets; ensure compliant marketing material approvals.
  • Measurement & Brand Alignment: Develop measurement processes and collaborate with brand marketing to align messages and insights.

Job Description

Own regional oncology market execution by translating scientific insights into commercial programs, leading cross-functional initiatives, and shaping speaker and advisory activities to drive regional impact.

  • Regional Engagement: Develop and execute the regional engagement plan for Stemline’s oncology/hematology products.
  • Cross-functional Leadership: Lead or serve as a key commercial member on high-visibility, company-wide initiatives.
  • Market Translation: Turn scientific, clinical, and market research into actionable commercial activities.
  • Advisory Boards & Medical Affairs: Develop and implement advisory boards across academic and community HCPs, partnering with medical affairs.
  • Stakeholder Interaction: Engage opinion leaders and oncology medical associations.
  • Regional Conference Planning: Develop and execute the Regional Conference plan for oncology meetings.
  • Speakers’ Bureaus: Build strategic and operational readiness plans for speakers’ bureaus (nomination, training, content).
  • Educational Content: Aid in Peer to Peer and Speaker Program content creation, such as slide decks and patient cases.
  • Regional Tactics & Compliance: Coordinate regional unbranded/branded tactics within strategy and budgets; ensure compliant marketing material approvals.
  • Measurement & Brand Alignment: Develop measurement processes and collaborate with brand marketing to align messages and insights.
Menarini Stemline logo

Menarini Stemline

3.6 Glassdoor

The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer. Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer. Netiquette & Privacy Notice: https://bit.ly/48X6JSN

Founded in 2003
New York, New York, USA
735 employees (47 in marketing)
58% recommend to a friend

Traffic Signals

Monthly Visitors
3.8K
Traffic Source Mix
Search
35%
Direct
42.9%
Referral
8.1%
Social
12.3%
Paid
1.3%

Headcount Trend

Current headcount: ~738

Marketing Team

Marketing Team Size
47 (6% of company)

Funding

Total Funding
$195.1M
Last Raise
$88M
Post IPO Equity, 7 years ago

Funding History

  • Aug 2019
    Post IPO Equity • $88M
  • Jan 2019
    Post IPO Equity • $92M
  • Jan 2012
    Debt Financing • $740K

Recent News